Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neuroblastoma in which the differentiating neuroblasts constitute more than five-percent of the tumor cells.
Biomarker and diagnostic research for differentiating neuroblastoma has been reported in the published literature.
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
3 publications have been identified in PubMed for differentiating neuroblastoma. Research spans Basic Science / Preclinical (67%) and Diagnostic / Biomarker (33%).
Wen J (2026). [PMID: 42246725](https://pubmed.ncbi.nlm.nih.gov/42246725/). *Radiol Imaging Cancer*. [Basic Science / Preclinical]
Li SQ (2025). [PMID: 40706419](https://pubmed.ncbi.nlm.nih.gov/40706419/). *Clin Radiol*. [Diagnostic / Biomarker]
Martin D (2024). [PMID: 40039460](https://pubmed.ncbi.nlm.nih.gov/40039460/). *Annu Int Conf IEEE Eng Med Biol Soc*. [Basic Science / Preclinical]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 11:55 PM UTC